Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with Defibrotide
Acta Haematologica · 2024
DOI: 10.1159/000535706 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Haematologica, 2024. Verfasst von Ram Vasudevan Nampoothiri und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Ottawa Hospital Transplantation and Cellular Therapy Program, University of Ottawa, Ottawa, Ontario, Canada, rvasudevan@toh.ca. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Hepatic Veno-Occlusive Disease, Biomarkers, Polydeoxyribonucleotides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Introduction
Despite well-established clinical criteria for diagnosis of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) following allogeneic hematopoietic cell transplantation (HCT), there is a lack of established diagnostic protein biomarkers.
Methods
Prospective samples were collected from patients with very severe SOS/VOD at diagnosis and days +3, +7, +14, and +30 post-initiation of defibrotide. Samples from age-matched controls with no VOD were collected at days +14, +30, +60, +90, and +180 following allogeneic HCT. Serum samples were analyzed for 2,925 protein levels by antibody-based proximity extension assay (PEA). Mean differences in the log-transformed abundance values were compared using t tests in a volcano plot.
Results
Five patients with very severe SOS/VOD and 5 control patients were compared. Ten proteins were identified that showed a statistically significant and log-transformed 3-fold increase in concentration. They were CALCA, CCL20, GPR37, IGFBP4, IL1RL1, SLC39A14, SPINK4, FABP3, MYL3, and CHCHD10. Four different proteins, namely, CD83, leukocyte associated immunoglobulin-like receptor 2 (LAIR2), CD7, and HEM6 showed a significant decrease with defibrotide treatment. SOS/VOD resolved in 80% (n = 4) of patients, while 1 patient deceased due to SOS/VOD.
Conclusion
PEA technology identified 10 proteins that were significantly elevated in patients with very severe SOS/VOD. Prospective studies in a larger cohort using this technology may be able to conclusively identify diagnostic protein biomarkers for SOS/VOD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Ottawa Hospital Transplantation and Cellular Therapy Program, University of Ottawa, Ottawa, Ontario, Canada, rvasudevan@toh.ca.
- Department of Biostatistics, University Health Network, University of Toronto, Toronto, Ontario, Canada.
- Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
- Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
- Department of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada.
Zitieren
APA
Vasudevan Nampoothiri, R., Avery, L., Pasic, I., Prassas, I., Diamandis, E., & Michelis, F. V. (2024). Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with Defibrotide. Acta Haematologica. https://doi.org/10.1159/000535706
Vancouver
Vasudevan Nampoothiri R, Avery L, Pasic I, Prassas I, Diamandis E, Michelis FV. Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with Defibrotide. Acta Haematologica. 2024. doi:10.1159/000535706
BibTeX
@article{VasudevanNampoothiri2024,
author = {Vasudevan Nampoothiri, Ram and Avery, Lisa and Pasic, Ivan and Prassas, Ioannis and Diamandis, Eleftherios and Michelis, Fotios V},
title = {Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with Defibrotide},
journal = {Acta Haematologica},
year = {2024},
doi = {10.1159/000535706}
}
EUVIMED